Pace Analytical Life Sciences Acquires Bio-Concept Laboratories

Pace Life Sciences Acquires Biopharma Global

September 8, 2022

Healthcare Services

Pace Life Sciences, a CDMO subsidiary of Pace, has acquired Biopharma Global, a Vienna, Virginia-based regulatory affairs consultancy that specializes in orphan and other high‑unmet‑need drug regulatory support. The acquisition expands Pace's regulatory strategy and submission capabilities for FDA and EMA filings, strengthening its end-to-end development and regulatory services for biotech and pharmaceutical clients.

Pace Life Sciences (Pace Analytical) Acquires Drug Delivery Experts

July 23, 2021

Pharmaceuticals

Pace Analytical Life Sciences, a CDMO subsidiary of Pace Analytical Services (itself a portfolio company of Aurora Capital Partners), has acquired Drug Delivery Experts, LLC, a San Diego-based CDMO specializing in complex injectable formulations and drug‑device combination product development. The acquisition expands Pace’s injectable and long‑acting/extended‑release capabilities and brings DDE’s scientific leadership into Pace’s west‑coast operations as DDE transitions to the Pace brand.

Pace Life Sciences Acquires Meridian BioGroup

August 18, 2022

Healthcare Services

Pace Life Sciences, a CDMO and subsidiary of Pace Science and Technology Company, has acquired Meridian BioGroup, a validation, regulatory, and compliance consulting provider based in Frederick, Maryland. The deal expands Pace's regulatory, quality and validation capabilities to better support biotechnology and pharmaceutical clients across development and commercialization.

Pace Analytical Services Acquires Alpha Analytical, LLC

March 7, 2023

Environmental Services

Pace Analytical Services, a division of Pace and a PE-backed national laboratory network, has acquired Alpha Analytical, LLC, a full-service environmental laboratory based in Westborough, Massachusetts. The deal expands Pace's geographic footprint and laboratory capabilities in the Northeast, adding multiple labs and service centers and strengthening testing services for emerging contaminants such as PFAS.

Pace Life Sciences Acquires Catalent's RTP Small-Molecule Analytical Services Laboratory

September 26, 2024

Healthcare Services

Pace Life Sciences, a PE-backed CDMO, has acquired Catalent’s Center-of-Excellence for Small Molecule Analytical Services located in Research Triangle Park, North Carolina. The acquisition expands Pace Life Sciences’ national analytical testing network (to nine sites) and strengthens its small- and large-molecule analytical capabilities to support biopharma clients; Catalent sold the site as part of its portfolio adjustments.

Pace Analytical Acquires Emerson Resources, Inc.

August 25, 2020

Pharmaceuticals

Pace Analytical Services, LLC acquired Emerson Resources, Inc., a CDMO specializing in solid oral dosage development and cGMP clinical trial material manufacturing. The acquisition expands Pace Life Sciences' capabilities to include clinical trial material production and transitions Emerson's Norristown, Pennsylvania lab into the Pace Analytical network while Emerson principals exit the business.